The 53,000-patient number is total from 5 different trials, where 4 of them with 11,700-patient each. This isn't that large for phase 4. FDA had asked for one with more than 20,000-patient safety trial BEFORE approval in the past. I'll leave it as a quiz.
Market Data 
Markets 
AI
